Technical Comparison
CRISPR Therapeutics AG - Common Shares vs NVIDIA Corporation - Common Stock
Real-time financial comparison matrix between CRSP and NVDA.
Primary Asset
CRS
CRISPR Therapeutics AG - Common Shares
Market Rank #1001207Live Price$47.99
Market Capitalization$4.7B
24h Change-0.93%
Circulating Supply98M CRSP
Comparison Asset
NVD
NVIDIA Corporation - Common Stock
Market Rank #101Live Price$200.75
Market Capitalization$4.9T
24h Change+2.93%
Circulating Supply24B NVDA
Market Metric Matrix
| Comparison Metric | CRSP Value | NVDA Value | Dominant Asset |
|---|---|---|---|
| Market Cap Rank | #1001207 | #101 | NVIDIA Corporation - Common Stock |
| Unit Price Valuation | $47.99 | $200.75 | NVIDIA Corporation - Common Stock |
| Total Liquid Cap | $4.7B | $4.9T | NVIDIA Corporation - Common Stock |
Frequently Asked Questions
Is CRISPR Therapeutics AG - Common Shares bigger than NVIDIA Corporation - Common Stock?
CRISPR Therapeutics AG - Common Shares has a market cap of $4.7B, while NVIDIA Corporation - Common Stock sits at $4.9T. Therefore, NVIDIA Corporation - Common Stock is currently the larger financial asset by market capitalization.
What is the price ratio between CRISPR Therapeutics AG - Common Shares and NVIDIA Corporation - Common Stock?
Currently, 1 CRSP is worth 0.24 NVDA.